The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Grace Therapeutics, Inc. insider acquisitions

Company CIK 0001444192 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
GRCE · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
PurchaseCode PCommon Stock, par value $0.0001 per shareNon-derivative · Currency not specified11314,085.36240

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Opaleye Management Inc.Opaleye Management Inc.Opaleye Management Inc. · October 19, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 16, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 15, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 14, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 12, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 9, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 8, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 5, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 2, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · October 1, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · September 29, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · September 23, 2026 · Purchase · Common Stock, par value $0.0001 per shareOpaleye Management Inc. · September 21, 2026 · Purchase · Common Stock, par value $0.0001 per shareSep 21, 2026Oct 19, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

13 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 19, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 16, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 15, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 14, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 12, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 9, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 8, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 5, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 2, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Oct 1, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Sep 29, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Sep 23, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase
Sep 21, 2026Grace Therapeutics, Inc.Common Stock, par value $0.0001 per shareOpaleye Management Inc.Purchase

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

GRCE · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P4,2561.88Value: 8,001.28Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P36,3471.8917 *Value: 68,757.6199Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P23,4851.9453 *Value: 45,685.3705Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P11,2331.9349 *Value: 21,734.7317Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P7,2152.02Value: 14,574.3Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P5,3402.0446 *Value: 10,918.164Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P2,0772.0175Value: 4,190.3475Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P1,6942.06Value: 3,489.64Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P20,0002.0684 *Value: 41,368Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P38,7962.0353 *Value: 78,961.4988Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P7,8492.09Value: 16,404.41Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P5,3182.1Value: 11,167.8Currency not specifiedView ↗
Trade: PurchaseCommon Stock, par value $0.0001 per shareNon-derivative security · Code P9,7712.1Value: 20,519.1Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →